Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nucana Plc ADR (NQ: NCNA ) 3.660 -4.070 (-52.65%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Nucana Plc ADR < Previous 1 2 Next > NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study August 29, 2024 From NuCana plc Via GlobeNewswire NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update August 15, 2024 From NuCana plc Via GlobeNewswire NuCana to Present at the Jefferies Global Healthcare Conference May 30, 2024 From NuCana plc Via GlobeNewswire NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit May 21, 2024 From NuCana plc Via GlobeNewswire NuCana Reports First Quarter 2024 Financial Results and Provides Business Update May 16, 2024 From NuCana plc Via GlobeNewswire NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement May 01, 2024 From NuCana plc Via GlobeNewswire NuCana Announces Completion of ADS Ratio Change April 16, 2024 From NuCana plc Via GlobeNewswire NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study April 09, 2024 From NuCana plc Via GlobeNewswire NuCana Announces Plan to Implement ADS Ratio Change March 27, 2024 From NuCana plc Via GlobeNewswire NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update March 20, 2024 From NuCana plc Via GlobeNewswire NuCana to Present at TD Cowen’s 44th Annual Health Care Conference February 27, 2024 From NuCana plc Via GlobeNewswire NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference February 06, 2024 From NuCana plc Via GlobeNewswire NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update November 16, 2023 From NuCana plc Via GlobeNewswire NuCana Announces Listing Transfer to Nasdaq Capital Market November 10, 2023 From NuCana plc Via GlobeNewswire NuCana to Present at the Jefferies London Healthcare Conference November 08, 2023 From NuCana plc Via GlobeNewswire NuCana to Participate in the Truist Securities 2023 BioPharma Symposium November 01, 2023 From NuCana plc Via GlobeNewswire NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 October 16, 2023 From NuCana plc Via GlobeNewswire NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 October 13, 2023 From NuCana plc Via GlobeNewswire NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 September 18, 2023 From NuCana plc Via GlobeNewswire NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update August 16, 2023 From NuCana plc Via GlobeNewswire NuCana to Present at the Jefferies Healthcare Conference June 01, 2023 From NuCana plc Via GlobeNewswire NuCana Reports First Quarter 2023 Financial Results and Provides Business Update May 17, 2023 From NuCana plc Via GlobeNewswire NuCana Announces Receipt of Nasdaq Notice May 12, 2023 From NuCana plc Via GlobeNewswire NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action April 14, 2023 From NuCana plc Via GlobeNewswire NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update April 04, 2023 From NuCana plc Via GlobeNewswire Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid March 24, 2023 Ruling Has No Impact on NuCana’s Anti-Cancer ProTide Patents From NuCana plc Via GlobeNewswire NuCana to Participate in Two Upcoming Investor Conferences February 28, 2023 From NuCana plc Via GlobeNewswire NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement January 23, 2023 From NuCana plc Via GlobeNewswire NuCana Announces Receipt of NASDAQ Notice January 06, 2023 From NuCana plc Via GlobeNewswire NuCana to Host Investor Meetings During the J.P. Morgan Healthcare Conference January 03, 2023 From NuCana plc Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.